These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2901257

  • 1. Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus.
    Sparks DL, DeKosky ST, Markesbery WR.
    Arch Neurol; 1988 Sep; 45(9):994-9. PubMed ID: 2901257
    [Abstract] [Full Text] [Related]

  • 2. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL, Hunsaker JC, Slevin JT, DeKosky ST, Kryscio RJ, Markesbery WR.
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [Abstract] [Full Text] [Related]

  • 3. [Alzheimer's disease and neurotransmitters].
    Nakamura S.
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):30-40. PubMed ID: 1672465
    [No Abstract] [Full Text] [Related]

  • 4. An update on the neurochemistry of Alzheimer disease.
    Davies P.
    Adv Neurol; 1983 Jan; 38():75-86. PubMed ID: 6137134
    [No Abstract] [Full Text] [Related]

  • 5. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P.
    Res Publ Assoc Res Nerv Ment Dis; 1979 Jan; 57():153-66. PubMed ID: 33427
    [No Abstract] [Full Text] [Related]

  • 6. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
    Rossor MN, Svendsen C, Hunt SP, Mountjoy CQ, Roth M, Iversen LL.
    Neurosci Lett; 1982 Feb 12; 28(2):217-22. PubMed ID: 7070710
    [Abstract] [Full Text] [Related]

  • 7. Sudden infant death syndrome: altered aminergic-cholinergic synaptic markers in hypothalamus.
    Sparks DL, Hunsaker JC.
    J Child Neurol; 1991 Oct 12; 6(4):335-9. PubMed ID: 1719064
    [Abstract] [Full Text] [Related]

  • 8. The effect of parenteral glutamate treatment on the localization of neurotransmitters in the mediobasal hypothalamus.
    Walaas I, Fonnum F.
    Brain Res; 1978 Sep 29; 153(3):549-62. PubMed ID: 29695
    [Abstract] [Full Text] [Related]

  • 9. Effect of surgical isolation of the hypothalamus on its neurotransmitter content.
    Brownstein MJ, Palkovits M, Tappaz ML, Saavedra JM, Kizer JS.
    Brain Res; 1976 Nov 26; 117(2):287-95. PubMed ID: 11035
    [Abstract] [Full Text] [Related]

  • 10. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
    Godridge H, Reynolds GP, Czudek C, Calcutt NA, Benton M.
    J Neurol Neurosurg Psychiatry; 1987 Jun 26; 50(6):775-8. PubMed ID: 2440994
    [Abstract] [Full Text] [Related]

  • 11. Alzheimer's disease and the new neuroscience.
    Wortis J.
    Biol Psychiatry; 1983 Aug 26; 18(8):847-8. PubMed ID: 6137248
    [No Abstract] [Full Text] [Related]

  • 12. Altered serotonergic and cholinergic synaptic markers in Pick's disease.
    Sparks DL, Markesbery WR.
    Arch Neurol; 1991 Aug 26; 48(8):796-9. PubMed ID: 1898253
    [Abstract] [Full Text] [Related]

  • 13. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG.
    Dan Med Bull; 1985 Feb 26; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract] [Full Text] [Related]

  • 14. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
    Yates CM, Simpson J, Gordon A, Maloney AF, Allison Y, Ritchie IM, Urquhart A.
    Brain Res; 1983 Nov 28; 280(1):119-26. PubMed ID: 6228286
    [Abstract] [Full Text] [Related]

  • 15. [Ageing and neurotransmitters].
    Nakamura S, Miyata S.
    Nihon Naika Gakkai Zasshi; 1985 Oct 28; 74(10):1348-52. PubMed ID: 2869092
    [No Abstract] [Full Text] [Related]

  • 16. Aging and Alzheimer's disease. Altered cortical serotonergic binding.
    Sparks DL.
    Arch Neurol; 1989 Feb 28; 46(2):138-40. PubMed ID: 2916952
    [Abstract] [Full Text] [Related]

  • 17. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
    Reinikainen KJ, Soininen H, Riekkinen PJ.
    J Neurosci Res; 1990 Dec 28; 27(4):576-86. PubMed ID: 1981917
    [Abstract] [Full Text] [Related]

  • 18. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
    Aisa B, Gil-Bea FJ, Solas M, García-Alloza M, Chen CP, Lai MK, Francis PT, Ramírez MJ.
    J Alzheimers Dis; 2010 Dec 28; 20(2):659-68. PubMed ID: 20164549
    [Abstract] [Full Text] [Related]

  • 19. Neurotransmitters and hypothalamic hormones in the central nervous system.
    Brownstein M.
    Fed Proc; 1977 Jun 28; 36(7):1960-3. PubMed ID: 16784
    [No Abstract] [Full Text] [Related]

  • 20. Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease.
    Rossor M, Iversen LL.
    Br Med Bull; 1986 Jan 28; 42(1):70-4. PubMed ID: 2869818
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.